Weak outlook from Pfizer overshadows 4Q performance
Pfizer's strong profit for the fourth quarter is being overshadowed by a tepid outlook for the year. The drugmaker on Tuesday had a loss of $394 million, or 7 cents ... Click to Co…
Pfizer's strong profit for the fourth quarter is being overshadowed by a tepid outlook for the year. The drugmaker on Tuesday had a loss of $394 million, or 7 cents ... Click to Co…